Literature DB >> 274741

Diet, genetics, and mental retardation interaction between phenylketonuric heterozygous mother and fetus to produce nonspecific diminution of IQ: evidence in support of the justification hypothesis.

S P Bessman, M L Williamson, R Koch.   

Abstract

The justification hypothesis postulates that an individual genetically deficient in the synthesis of any of the 12 nonessential amino acids requires that amino acid in the diet just as a normal individual requires any essential amino acid. The deficiency of that single amino acid causes diminished protein synthesis. The hypothesis proposes that mental retardation develops during the late stage of fetal development, when the brain is growing most rapidly, as a result of the inability of the mother to deliver an appropriate amount of that nonessential amino acid to her fetus who, in turn, is unable to correct for this deficiency due to his genetic constitution. A paradigm is provided by the disease phenylketonuria in which the homozygote lacks the enzyme for synthesis of the nonessential amino acid tyrosine. By measuring the appearance of tyrosine in the plasma after an oral dose of phenylalanine, it is possible to show differential capability among siblings of known phenylketonuric children, in the expected Mendelian ratio. The mean IQ of the two-thirds of the siblings who were least able to convert phenylalanine to tyrosine (presumably heterozygotes) was 10 points lower than the mean IQ of the "normals," who were most able to synthesize tyrosine. The difference is statistically significant (P <0.01). The mean maternal IQ was halfway between that of the heterozygote group and that of the normal group, confirming the prediction of maternal-fetal interaction.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 274741      PMCID: PMC411514          DOI: 10.1073/pnas.75.3.1562

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  STUDIES ON FAMILIES OF PHENYLKETONURICS: OBSERVATIONS ON INTELLIGENCE AND ELECTROENCEPHALOGRAPHIC CHANGES.

Authors:  R O FISCH; L K SINES; F TORRES; J A ANDERSON
Journal:  Am J Dis Child       Date:  1965-05

2.  A fluorometric method for the estimation of tyrosine in plasma and tissues.

Authors:  T P WAALKES; S UDENFRIEND
Journal:  J Lab Clin Med       Date:  1957-11

3.  Changes in the heterozygotes for pku and their possible relationship to the environment in utero.

Authors:  V A Cowie
Journal:  Ir Med J       Date:  1976-09-30

4.  Phenylpyruvic oligophrenia.

Authors:  V COWIE
Journal:  J Ment Sci       Date:  1951-07

5.  Nutritional management of the female with phenylketonuria during pregnancy.

Authors:  S M Pueschel; C Hum; M Andrews
Journal:  Am J Clin Nutr       Date:  1977-07       Impact factor: 7.045

6.  Genetic divergence in relatives of PKU's: low IQ correlation among normal siblings.

Authors:  R N Fuller; J B Shuman
Journal:  Dev Psychobiol       Date:  1974-07       Impact factor: 3.038

7.  Classic phenylketonuria: heterozygote detection during pregnancy.

Authors:  R F Griffin; M E Humienny; E C Hall; L J Elsas
Journal:  Am J Hum Genet       Date:  1973-11       Impact factor: 11.025

8.  Genetic failure of fetal amino acid "justification": a common basis for many forms of metabolic, nutritional, and "nonspecific" mental retardation.

Authors:  S P Bessman
Journal:  J Pediatr       Date:  1972-10       Impact factor: 4.406

9.  Glutamine in the phenylketonuric central nervous system.

Authors:  C M McKean; N A Peterson
Journal:  N Engl J Med       Date:  1970-12-17       Impact factor: 91.245

10.  Phenylalanine metabolism and intellectual functioning among carriers of phenylketonuria and hyperphenylalaninaemia.

Authors:  R C Ford; J L Berman
Journal:  Lancet       Date:  1977-04-09       Impact factor: 79.321

View more
  8 in total

1.  Neuropsychological profile in parents of adult phenylketonuria patients.

Authors:  Gabriella Santangelo; Fausta Piscopo; Franco Santangelo; Luigi Trojano
Journal:  Neurol Sci       Date:  2017-11-09       Impact factor: 3.307

2.  Maternal PKU syndrome in an exceptional family with unexpected PKU.

Authors:  J B De Klerk; S K Wadman; H J Dijkhuis; E E Meuleman
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

Review 3.  Inherited metabolic diseases affecting the carrier.

Authors:  W Endres
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982

4.  Four cases of hyperphenylalaninaemia: studies during pregnancy and of the offspring produced.

Authors:  R Koch; M Blaskovics
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

5.  Bony changes of PKU neonates unrelated to phenylalanine levels.

Authors:  R O Fisch; S B Feinberg; S Weisberg; D Day
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

Review 6.  Gestational carrier--a reproductive haven for offspring of mothers with phenylketonuria (PKU): an alternative therapy for maternal PKU.

Authors:  R O Fisch; G Tagatz; J P Stassart
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

Review 7.  Diseases of phenylalanine metabolism.

Authors:  C E Parker
Journal:  West J Med       Date:  1979-10

8.  Cord-blood tyrosine levels in the full-term phenylketonuric fetus and the "justification hypothesis".

Authors:  C R Scriver; D E Cole; S A Houghton; H L Levy; A Grenier; C Laberge
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.